Evidence map›Paper›PMID 38879412›Full record

ArticleDisability and health journal2024

Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilities.

Julie H Levison, Vicki Fung, Anna Wilson, David Cheng, Karen Donelan, Nicolas M Oreskovic, Ronita Samuels, Paula Silverman, Joey Batson, Ahmed Fathi and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disability and health journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Julie H LevisonMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Massachusetts General Hospital, Department of Medicine, 55 Fruit St, Gray 7-730, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA. Electronic address: jlevison@mgb.org.
Vicki FungMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Anna WilsonMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA.
David ChengMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA; Massachusetts General Hospital, Biostatistics Center, 50 Staniford Street, Suite 560, Boston, MA, 02114, USA.
Karen DonelanMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Heller School for Social Policy and Management, Brandeis University, 415 South St, Waltham, MA, 02453, USA.
Nicolas M OreskovicHarvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA; Massachusetts General Hospital, Department of Pediatrics, Division of Medical Genetics and Metabolism, Down Syndrome Program, 125 Nashua Street, Suite 821, Boston, MA, 02114, USA.
Ronita SamuelsMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA.
Paula SilvermanVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Joey BatsonVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Ahmed FathiVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Stefanie GamseVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Sibyl HollandVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Jessica E BeckerNYU Grossman School of Medicine and NYU Langone Health, Department of Child and Adolescent Psychiatry, 550 First Avenue, New York, NY, 10016, USA.
Kenneth A FreedbergMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Massachusetts General Hospital, Department of Medicine, 55 Fruit St, Gray 7-730, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Lisa I IezzoniMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Amy DonohueAdvocates, Inc. 1881 Worcester Rd, Framingham, MA, 01701, USA.
Mark VironAdvocates, Inc. 1881 Worcester Rd, Framingham, MA, 01701, USA.
Carley LubarskyBay Cove Human Services, 66 Canal Street, Boston, MA, 02114, USA.
Terina KellerBay Cove Human Services, 66 Canal Street, Boston, MA, 02114, USA.
Jean-Louise ReichmanNorth Suffolk Mental Health Association, 301 Broadway, Chelsea, MA, 02150, USA.
Bettina BastienRiverside Community Care, 270 Bridge Street, Suite 301, Dedham, MA, 02026, USA.
Elizabeth RyanVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Alexander C TsaiMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
John HsuMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, Department of Medicine, 25 Shattuck Street, Boston, MA, 02115, USA; Harvard Medical School, Department of Health Care Policy, 180 Longwood Avenue, Boston, MA, 02115, USA.
Cindy ChauMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA.
David KraneMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA.
Hao D TrieuMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA.
Jessica WolfeVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Kim ShellenbergerVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Elizabeth CellaVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Bruce BirdVinfen Corporation, 950 Cambridge Street, Cambridge, MA, 02141, USA.
Stephen BartelsMassachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Massachusetts General Hospital, Department of Medicine, 55 Fruit St, Gray 7-730, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Brian G SkotkoHarvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA; Massachusetts General Hospital, Department of Pediatrics, Division of Medical Genetics and Metabolism, Down Syndrome Program, 125 Nashua Street, Suite 821, Boston, MA, 02114, USA.

Funding

Training in Child Health Services Research and Implementation ScienceT32HS000063 · AHRQ · CHILDREN'S HOSPITAL BOSTON · PI GARABEDIAN, LAURA FADEN, WALSH, KATHLEEN ELIZABETH · 1994 to 2024
$7.6M
AHRQ HHS T32 HS000063
6 · The paper itself

Abstract

backgroundMore than seven million people with intellectual and/or developmental disabilities (ID/DD) live in the US and may face an elevated risk for COVID-19.

objectiveTo identify correlates of COVID-19 and related hospitalizations among people with ID/DD in group homes in Massachusetts.

methodsWe collected data during March 1, 2020-June 30, 2020 (wave 1) and July 1, 2020-March 31, 2021 (wave 2) from the Massachusetts Department of Public Health and six organizations administering 206 group homes for 1035 residents with ID/DD. The main outcomes were COVID-19 infections and related hospitalizations. We fit multilevel Cox proportional hazards models to estimate associations with observed predictors and assess contextual home- and organizational-level effects.

resultsCompared with Massachusetts residents, group home residents had a higher age-adjusted rate of COVID-19 in wave 1 (incidence rate ratio [IRR], 12.06; 95 % confidence interval [CI], 10.51-13.84) and wave 2 (IRR, 2.47; 95 % CI, 2.12-2.88) and a higher age-adjusted rate of COVID-19 hospitalizations in wave 1 (IRR, 17.64; 95 % CI, 12.59-24.70) and wave 2 (IRR, 4.95; 95 % CI, 3.23-7.60). COVID-19 infections and hospitalizations were more likely among residents aged 65+ and in group homes with 6+ resident beds and recent infection among staff and residents.

conclusionsAggressive efforts to decrease resident density, staff-to-resident ratios, and staff infections through efforts such as vaccination, in addition to ongoing access to personal protective equipment and COVID-19 testing, may reduce COVID-19 and related hospitalizations in people with ID/DD living in group homes.

Indexed as

COVID-19Developmental DisabilitiesGroup HomesHospitalizationIntellectual DisabilityAdolescentAdultAgedFemaleHumansMaleMassachusettsMiddle AgedPersons with DisabilitiesProportional Hazards ModelsRisk FactorsCongregate living settingsCOVID-19DisabilitiesGroup homesSARS-CoV-2

Identifiers

PMID38879412
PMCPMC11454325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.